Editorials
Balancing benefits and harms in health care
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7406.65 (Published 10 July 2003) Cite this as: BMJ 2003;327:65
Related articles
- Paper Published: 06 October 2005; BMJ 331 doi:10.1136/bmj.38569.471007.AE
- PAPERS Published: 12 September 2005; BMJ doi:10.1136/bmj.38569.471007.AE
- Letter Published: 25 September 2003; BMJ 327 doi:10.1136/bmj.327.7417.750-a
- Letter Published: 25 September 2003; BMJ 327 doi:10.1136/bmj.327.7417.750-b
See more
- Anaesthetists feel broadly negative about associates, survey findsBMJ April 10, 2024, 385 q839; DOI: https://doi.org/10.1136/bmj.q839
- Cardiac arrest occurs in three in 10 000 surgeries involving anaesthesia, audit findsBMJ November 20, 2023, 383 p2737; DOI: https://doi.org/10.1136/bmj.p2737
- Anaesthesia associates: Royal college convenes extraordinary meeting after call from membersBMJ September 11, 2023, 382 p2076; DOI: https://doi.org/10.1136/bmj.p2076
- Ethnic inequalities in how care is given, not just in access and outcomesBMJ July 11, 2023, 382 p1589; DOI: https://doi.org/10.1136/bmj.p1589
- Learning from complaints during covid-19: discuss risks and benefits before hospital treatmentBMJ July 27, 2022, 378 o1858; DOI: https://doi.org/10.1136/bmj.o1858
Cited by...
- Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
- Benefits and harms of drug treatments
- Collecting and sharing information about harms
- Synthesising licensing data to assess drug safety
- How to spot bias and other potential problems in randomised controlled trials
- Balancing benefits and harms in health care: Observational data on harm are already included in systematic reviews
- Balancing benefits and harms in health care: Observational data on harm should complement systematic reviews of benefit